Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001219036-21-000014

Chief Scientific Officer sold 32,308 shares at an average $32.27 ($1,042,660)

  • Chief Scientific Officer acquired 32,308 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LANCHBURY JERRY S · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-07-07 Exercise or conversion : show line 1 in the form +30,424 $26.49 $805,932 262,974 D
2021-07-07 Sale : show line 2 in the form −30,424 $32.29 $982,391 232,550 D
2021-07-07 Exercise or conversion : show line 3 in the form +1,884 $26.49 $49,907 234,434 D
2021-07-07 Sale : show line 4 in the form −1,884 $31.99 $60,269 232,550 D
Open-market sales · 32,308 sh · avg $32.27 · $1,042,660

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-07-07 Exercise or conversion : show line 5 in the form Incentive Stock Option (right to buy) −1,884 0 D
2021-07-07 Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) −30,424 141,828 D
Loading xslF345X03/edgardoc.xml…